Inflammatory Bowel Disease

Twice as many responders achieved clinical remission at week 40 versus placebo

Swedish study is largest, with longest follow-up to date

Compared with placebo, the JAK inhibitor improved clinical remission and endoscopic response

Upadacitinib lands indication for moderately to severely active disease in adults

Trial boosts case for label expansion

Other measures of physical fitness not independently associated with IBD risk

Biologic effective for common complication of ileal pouch-anal anastomosis in ulcerative colitis

Though next steps for olamkicept in ulcerative colitis a bit unclear

Golden Globe winner talks about his health ordeal

Intestinal as well as brain-related problems found in study that used wrist actigraphy devices

Specialists in both fields need to communicate and coordinate, says researcher

Literature review highlights benefits, although access is an issue, expert says

Study finds no appetite for long-term adherence; lack of targeted education

App measured heart rate variability metrics in patients with Crohn's, ulcerative colitis